Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Treatment”

1,520 trials

Showing 20 of 1,520 results

Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Ended earlyNCT00122551
What this trial is testing

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 400
Testing effectiveness (Phase 2)Study completedNCT02071095
What this trial is testing

Enhancement by Poly-ICLC During HIV-1 Infection

Who this might be right for
HIV-1 Infected Adults With Chronic HIV-1 Infection
Nina Bhardwaj 15
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Not applicableStudy completedNCT01333644
What this trial is testing

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Who this might be right for
HIV InfectionCardiovascular DiseaseInflammation
University of California, San Francisco 270
Not applicableStudy completedNCT04470011
What this trial is testing

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia

Who this might be right for
HIVAntiretroviral Therapy
Boston University 2,189
Early research (Phase 1)Study completedNCT00001644
What this trial is testing

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableStudy completedNCT03880006
What this trial is testing

Universal Coverage of Antiretroviral Treatment in Senegal

Who this might be right for
HIV/AIDS
Johns Hopkins Bloomberg School of Public Health 596
Early research (Phase 1)Study completedNCT02413645
What this trial is testing

Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients

Who this might be right for
HIV-infection
Judit Pich Martínez 21
Not applicableUnknownNCT05996081
What this trial is testing

Adherence Toolkit for Managing Nonadherence to HIV Medications in Indonesia

Who this might be right for
AdultHIV Infections
University of Groningen 400
Post-approval studies (Phase 4)Study completedNCT04549467
What this trial is testing

Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test

Who this might be right for
HivHIV-1-infection
Fundacion IDEAA 244
Testing effectiveness (Phase 2)Study completedNCT01717287
What this trial is testing

The Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 32
Not applicableStudy completedNCT02677675
What this trial is testing

Effectiveness of Mobile Phone Technology on Adherence and Treatment Outcomes Among HIV Positive Patients on ART

Who this might be right for
HIV
Universiti Putra Malaysia 242
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Post-approval studies (Phase 4)Study completedNCT04880395
What this trial is testing

Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Who this might be right for
HIV-1-infection
Fundación Huésped 265
Not applicableStudy completedNCT03367130
What this trial is testing

Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal

Who this might be right for
HIV InfectionsAntiretroviral TherapyHIV Seropositivity
Tokyo University 468
Large-scale testing (Phase 3)Ended earlyNCT02247687
What this trial is testing

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

Who this might be right for
HIV-1 InfectionTreatment Resistant DisordersViremia
ANRS, Emerging Infectious Diseases 4
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation